HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients

BACKGROUND: Optimizing HCV genotype 1 therapy in terms of response prediction and tailoring treatment is undoubtedly the cornerstone of treating HIV co-infected patients in clinical practice. Accordingly, our aim was to analyze the predictive value of HCV viral decline for sustained virological resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivero-Juarez, Antonio, López-Cortés, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Gordon, Ana, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Pineda, Juan A., Viciana, Pompeyo, Rivero, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063713/
https://www.ncbi.nlm.nih.gov/pubmed/24945348
http://dx.doi.org/10.1371/journal.pone.0099468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063713/
https://www.ncbi.nlm.nih.gov/pubmed/24945348
http://dx.doi.org/10.1371/journal.pone.0099468

Ejemplares similares